Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
BTB and CNC homolog 1 (BACH1) promotes transformation, cell proliferation and tumor formation in a model of activated RAS transfected-mouse embryonic fibroblasts (MEFs). We focused on the role of BACH1 in the pancreatic ductal adenocarcinoma (PDAC) more than 90% of which has KRAS mutation. Although BACH1 did not affect cell proliferation and tumor growth, but promoted migration ability and invasion ability in vitro and metastasis in vivo. We revealed that BACH1 repressed directly the expression of multiple epithelial-related genes as its mechanism. We showed also BACH1 is a poor prognostic factor on PDAC.
|